Alamar Biosciences Raises 2026 Revenue Guidance to $121M–$123M
The company’s full-year 2026 revenue outlook is above the FactSet consensus estimate of $118.6 million.
Alamar Biosciences, Inc. has provided updated revenue guidance for the full year 2026, projecting a range of $121 million to $123 million. This outlook exceeds the FactSet consensus estimate of $118.6 million. The updated guidance reflects the company's current business trajectory and market expectations for its proteomics platform.